Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
442.17
-1.08 (-0.24%)
At close: Sep 4, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $352.29 billion as of September 4, 2026. Its market cap has increased by 30.79% in one year.
Market Cap
352.29B
Enterprise Value
386.37B
Revenue
77.92B
Ranking
n/a
PE Ratio
23.07
Stock Price
$442.17
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 352.29B, an increase of 3,922.11%. That is a compound annual growth rate of 11.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 352.29B | 6.26% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 890.50M |
| Veradigm | 512.26M |
| Nika Pharmaceuticals | 431.19M |
| American Oncology Network | 337.32M |
| Elite Pharmaceuticals | 297.51M |
| Northwest Biotherapeutics | 288.94M |
| CytoDyn | 287.02M |
| Glorywin Entertainment Group | 234.77M |